Tokyo Front

タミフル

【 full Tami 】Oral type anti-influenza virus medicine that pharmaceutical company "Rosh (Roche)" of Switzerland manufactures. It puts it on the market from Chugai Pharmaceutical in Japan (The hospital recipe is necessary). It begins to drink for the adult within 48 hours after it develops now, and one capsule is supposed to be taken for five days in the morning and evening. Proliferation is suppressed by preventing the virus from diffusing, and there is an effect of recovering the symptom early. The side effect in the post-marketing surveillance study is nausea etc. to which it has loose bowels by 1.8%. Moreover, there is a point that the death and the abnormal behavior might be suddenly caused by the side effect such as minors. Japan : more than the half of production at last season.